Literature DB >> 21104333

Modeling the primary oxidation in commercial fish oil preparations.

Jenna C Sullivan1, Suzanne M Budge, Marc St-Onge.   

Abstract

The quality of commercial fish oil products can be difficult to maintain because of the rapid lipid oxidation attributable to the high number of polyunsaturated fatty acids (PUFA), specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). While it is known that oxidation in fish oil is generally the result of a direct interaction with oxygen and fatty acid radicals, there are very few studies that investigate the oxidation kinetics of fish oil supplements. This study uses hydroperoxides, a primary oxidation product, to model the oxidation kinetics of two commercially available fish oil supplements with different EPA and DHA contents. Pseudo first order kinetics were assumed, and rate constants were determined for temperatures between 4 and 60 °C. This data was fit to the Arrhenius model, and activation energies (E(a)) were determined for each sample. Both E(a) agreed with values found in the literature, with the lower PUFA sample having a lower E(a). The oil with a lower PUFA content fit the first-order kinetics model at temperatures ≥20 °C and ≤40 °C, while the higher PUFA oil demonstrated first-order kinetics at temperatures ≥4 °C and ≤40 °C. When the temperature was raised to 60 °C, the model no longer applied. This indicates that accelerated testing of fish oil should be conducted at temperatures ≤40 °C.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21104333     DOI: 10.1007/s11745-010-3500-6

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  6 in total

1.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.

Authors:  Penny M Kris-Etherton; William S Harris; Lawrence J Appel
Journal:  Circulation       Date:  2002-11-19       Impact factor: 29.690

Review 2.  Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids.

Authors:  Alexander Leaf
Journal:  Fundam Clin Pharmacol       Date:  2006-12       Impact factor: 2.748

3.  Autoxidation kinetic analysis of docosahexaenoic acid ethyl ester and docosahexaenoic triglyceride with oxygen sensor.

Authors:  Hidefumi Yoshii; Takeshi Furuta; Hirokazu Siga; Shigeru Moriyama; Takashi Baba; Kazuaki Maruyama; Yoshihisa Misawa; Noriaki Hata; Pekka Linko
Journal:  Biosci Biotechnol Biochem       Date:  2002-04       Impact factor: 2.043

4.  Fish and omega-3 fatty acid intake and risk of coronary heart disease in women.

Authors:  Frank B Hu; Leslie Bronner; Walter C Willett; Meir J Stampfer; Kathryn M Rexrode; Christine M Albert; David Hunter; JoAnn E Manson
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

Review 5.  Dietary omega 3 fatty acids and the developing brain.

Authors:  Sheila M Innis
Journal:  Brain Res       Date:  2008-09-09       Impact factor: 3.252

Review 6.  Omega-3 fatty acids in health and disease and in growth and development.

Authors:  A P Simopoulos
Journal:  Am J Clin Nutr       Date:  1991-09       Impact factor: 7.045

  6 in total
  4 in total

1.  Key lipid oxidation products can be used to predict sensory quality of fish oils with different levels of EPA and DHA.

Authors:  Jenna C Sullivan Ritter; Suzanne M Budge
Journal:  Lipids       Date:  2012-10-25       Impact factor: 1.880

2.  The Potential of Phaeodactylum as a Natural Source of Antioxidants for Fish Oil Stabilization.

Authors:  Robbe Demets; Simon Van Broekhoven; Lore Gheysen; Ann Van Loey; Imogen Foubert
Journal:  Foods       Date:  2022-05-18

3.  Pro- and Antioxidative Effect of α-Tocopherol on Edible Oils, Triglycerides and Fatty Acids.

Authors:  Maria Jerzykiewicz; Irmina Cwieląg-Piasecka; Adam Jezierski
Journal:  J Am Oil Chem Soc       Date:  2013-03-15       Impact factor: 1.849

Review 4.  New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease.

Authors:  R Preston Mason
Journal:  Curr Atheroscler Rep       Date:  2019-01-12       Impact factor: 5.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.